Skip to main content

Advertisement

SpringerLink
Log in

Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

The aims were to evaluate the performance of models that predict Gleason Grade (GG) groups with radiomic data obtained from the prostate gland in dual time 68Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computerized Tomography (PET/CT) images for prostate cancer (PCa) staging, and to analyze the contribution of late imaging to the radiomic model and to evaluate the relationship of the distance between tumor foci in the body (Dmax) obtained in early PET images with histopathology and prostate specific antigen (PSA) value.

Methods

Between October 2020 and August 2021, 41 patients who underwent 68Ga-PSMA PET/CT for staging of PCa were retrospectively analyzed. Volumetric and radiomics data were obtained from early and late PSMA PET images. The differences between age, metastasis status, PSA, standard uptake value (SUV), volumetric and radiomics parameters between GG groups were analyzed. Early and late PET radiomic models were created, area under curve (AUC), sensitivity, specificity and accuracy values of the models were obtained. In addition, the correlation of Dmax values with total PSMA-tumor volume (TV), Total lesion (TL)-PSMA and PSA values was evaluated. In metastatic patients, the difference in Dmax between GG groups was analyzed.

Results

There was a significant difference between patients with GG ≤ 3 and > 3 in 35 of the early PET radiomic features. In the early PET model, multivariate analyses showed that GLRLM_RLNU and PSA were the most meaningful parameters. The AUC, sensitivity, specificity and accuracy values of the early model in detecting patients with GG > 3 were calculated as 0.902, 76.2%, 84% and 78.1%, respectively. In 36 late PET radiomic features, there was a significant difference between patients with GG ≤ 3 and > 3. In multivariate analyses; SHAPE_compacity and PSA were obtained as the most meaningful parameters. The AUC, sensitivity, specificity and accuracy values of the late model in detecting patients with GG > 3 were calculated as 0.924, 85.7%, 85% and 85.4%. There was a strong correlation between Dmax and PSA values (p < 0.001, rho: 0.793). Dmax showed strong correlation with PSMA-TVtotal and TL-PSMAtotal (p < 0.001, rho: 0.797; p < 0.001, rho: 0.763, respectively). In patients with metastasis, median Dmax values of the GG > 3 group were higher than GG ≤ 3 group; A statistically significant difference was obtained between these two groups (p = 0.023).

Conclusions

Model generated from the late PSMA PET radiomic data had better performance in the current study. Without the use of invasive methods, the heterogeneity and aggressiveness of the primary tumor and the prediction of GG groups may be possible with 68Ga-PSMA PET/CT images obtained for diagnostic purposes especially with late PSMA PET/CT imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40(4):486–95.

    Article  CAS  Google Scholar 

  2. Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid 68Ga-PSMA Ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56(5):668–74.

    Article  Google Scholar 

  3. Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG, et al. Sensitivity, specificity, and predictors of positive (68)Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analyses. Eur Urol. 2016;70:926–37.

    Article  Google Scholar 

  4. Han S, Woo S, Kim YJ, Suh CH. Impact of (68)Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analyses. Eur Urol. 2018;74(2):179–90.

    Article  CAS  Google Scholar 

  5. Schmidkonz C, Cordes M, Schmidt D, Bauerle T, Goetz TI, Beck M, et al. (68)Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. Eur J Nucl Med Mol Imaging. 2018;45(11):1862–72.

    Article  Google Scholar 

  6. Schmuck S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, et al. Initial experience with volumetric 68Ga-PSMA I&T PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med. 2017;58(12):1962–8.

    Article  CAS  Google Scholar 

  7. Acar E, Özdoğan Ö, Aksu A, Derebek E, Bekiş R, Çapa KG. The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival. Ann Nucl Med. 2019;33(9):681–8.

    Article  Google Scholar 

  8. Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O, et al. 18F-FDG PET dissemination features in diffuse large B-Cell lymphoma are predictive of outcome. J Nucl Med. 2020;61(1):40–5.

    Article  Google Scholar 

  9. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures. They are data. Radiology. 2016;278(2):563–77.

    Article  Google Scholar 

  10. Hyun SH, Ahn MS, Koh YW, Lee SJ. A machine-learning approach using PET-based radiomics to predict the histological subtypes of lung cancer. Clin Nucl Med. 2019;44(12):956–60.

    Article  Google Scholar 

  11. Li Y, Zhang Y, Fang Q, Zhang X, Hou P, Wu H, et al. Radiomics analyses of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(8):2599–614.

    Article  CAS  Google Scholar 

  12. Polverari G, Ceci F, Bertaglia V, Reale ML, Rampado O, Gallio E, et al. 18F-FDG pet parameters and radiomics features analyses in advanced Nsclc treated with immunotherapy as predictors of therapy response and survival. Cancers (Basel). 2020;12(5):1163.

    Article  CAS  Google Scholar 

  13. Giannini V, Mazzetti S, Bertotto I, Chiarenza C, Cauda S, Delmastro E, et al. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging. 2019;46(4):878–88.

    Article  CAS  Google Scholar 

  14. Zamboglou C, Carles M, Fechter T, Kiefer S, Reichel K, Fass-bender TF, et al. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer—a comparison study with histology reference. Theranostics. 2019;9(9):2595–605.

    Article  CAS  Google Scholar 

  15. Zamboglou C, Bettermann AS, Gratzke C, Mix M, Ruf J, Kiefer S, et al. Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48(6):1987–97.

    Article  CAS  Google Scholar 

  16. Papp L, Spielvogel CP, Grubmüller B, Grahovac M, Krajnc D, Ecsedi B, et al. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI. Eur J Nucl Med Mol Imaging. 2021;48(6):1795–805.

    Article  CAS  Google Scholar 

  17. Alberts I, Sachpekidis C, Dijkstra L, Prenosil G, Gourni E, Boxler S, et al. The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia. Eur J Nucl Med Mol Imaging. 2020;47:642–51. https://doi.org/10.1007/s00259-019-04552-9.

    Article  CAS  PubMed  Google Scholar 

  18. Schmuck S, Mamach M, Wilke F, von Klot CA, Henkenberens C, Thackeray JT, Sohns JM, et al. Multiple time-point 68Ga-PSMA I&T PET/CT for characterization of primary prostate cancer: value of early dynamic and delayed imaging. Clin Nucl Med. 2017;42:286–93.

    Article  Google Scholar 

  19. Nioche C, Orlhac F, Soussan M, Boughdad S, Alberini J, Buvat I. A software for characterizing intra-tumor heterogeneity in multimodality imaging and establishing reference charts. Eur J Nucl Med Mol Imaging. 2016;43:S156–7.

    Google Scholar 

  20. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2016;40(2):244–52.

    Article  Google Scholar 

  21. Rowe SP, Pienta KJ, Pomper MG, Gorin MA. PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies. Eur Urol. 2018;73(4):485–7.

    Article  Google Scholar 

  22. Hammes J, Täger P, Drzezga A. EBONI: a tool for automated quantification of bone metastasis load in PSMA PET/CT. J Nucl Med. 2018;59(7):1070–5. https://doi.org/10.2967/jnumed.117.203265 (Epub 2017 Dec 14).

    Article  CAS  PubMed  Google Scholar 

  23. Chan YH. Biostatistics 104: correlational analyses. Singap Med J. 2003;44:614–9.

    CAS  Google Scholar 

  24. Aksu A, Karahan Şen NP, Tuna EB, Aslan G, Çapa KG. Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients. Nucl Med Commun. 2021;42(5):503–9.

    Article  CAS  Google Scholar 

  25. Shiri I, Rahmim A, Ghaffarian P, Geramifar P, Abdollahi H, Bitarafan-Rajabi A. The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies. Eur Radiol. 2017;27(11):4498–509.

    Article  Google Scholar 

  26. Leijenaar RT, Nalbantov G, Carvalho S, van Elmpt WJ, Troost EG, Boellaard R, et al. The effect of SUV discretization in quantitative FDG-PET radiomics: the need for standardized methodology in tumor texture analyses. Sci Rep. 2015;5(5):11075.

    Article  CAS  Google Scholar 

  27. van Velden FH, Kramer GM, Frings V, Nissen IA, Mulder ER, de Langen A, et al. Repeatability of radiomic features in non-small-cell lung cancer [(18)F]FDG-PET/CT studies: ımpact of reconstruction and delineation. Mol Imaging Biol. 2016;18(5):788–95.

    Article  Google Scholar 

Download references

Funding

The authors received no financial support for the research and/or authorship of this article.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Başakşehir Cam and Sakura City Hospital, Istanbul, Turkey

    Ayşegül Aksu, Özge Vural Topuz, Gülşah Yılmaz & Burçak Yılmaz

  2. Department of Nuclear Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey

    Gamze Çapa Kaya

Authors
  1. Ayşegül Aksu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Özge Vural Topuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gülşah Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gamze Çapa Kaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Burçak Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ayşegül Aksu.

Ethics declarations

Conflict of interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aksu, A., Vural Topuz, Ö., Yılmaz, G. et al. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Ann Nucl Med 36, 310–318 (2022). https://doi.org/10.1007/s12149-021-01705-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-021-01705-5

Keywords

Search

Navigation